Literature DB >> 28967877

Osteopontin and the immune system: another brick in the wall.

Sara Caputo1, Matteo Bellone2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28967877      PMCID： PMC6052835          DOI： 10.1038/cmi.2017.94

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  15 in total

1.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

Authors:  S Ashkar; G F Weber; V Panoutsakopoulou; M E Sanchirico; M Jansson; S Zawaideh; S R Rittling; D T Denhardt; M J Glimcher; H Cantor
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

Review 2.  Role of osteopontin in the pathophysiology of cancer.

Authors:  Lalita A Shevde; Rajeev S Samant
Journal:  Matrix Biol       Date:  2014-03-19       Impact factor: 11.583

Review 3.  Emergency granulopoiesis.

Authors:  Markus G Manz; Steffen Boettcher
Journal:  Nat Rev Immunol       Date:  2014-04-22       Impact factor: 53.106

Review 4.  Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases.

Authors:  Toshimitsu Uede
Journal:  Pathol Int       Date:  2011-03-08       Impact factor: 2.534

5.  Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell Activation.

Authors:  Elena Jachetti; Sara Caputo; Stefania Mazzoleni; Chiara Svetlana Brambillasca; Sara Martina Parigi; Matteo Grioni; Ignazio Stefano Piras; Umberto Restuccia; Arianna Calcinotto; Massimo Freschi; Angela Bachi; Rossella Galli; Matteo Bellone
Journal:  Cancer Res       Date:  2015-03-25       Impact factor: 12.701

6.  Osteopontin shapes immunosuppression in the metastatic niche.

Authors:  Sabina Sangaletti; Claudio Tripodo; Sara Sandri; Ilaria Torselli; Caterina Vitali; Chiara Ratti; Laura Botti; Alessia Burocchi; Rossana Porcasi; Andrea Tomirotti; Mario P Colombo; Claudia Chiodoni
Journal:  Cancer Res       Date:  2014-07-17       Impact factor: 12.701

7.  Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis.

Authors:  Gopal Murugaiyan; Akanksha Mittal; Howard L Weiner
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

8.  Osteopontin as two-sided mediator of intestinal inflammation.

Authors:  Katja Heilmann; Ute Hoffmann; Ellen Witte; Christoph Loddenkemper; Christian Sina; Stefan Schreiber; Claudia Hayford; Pamela Holzlöhner; Kerstin Wolk; Elianne Tchatchou; Verena Moos; Martin Zeitz; Robert Sabat; Ursula Günthert; Bianca Maria Wittig
Journal:  J Cell Mol Med       Date:  2008-07-04       Impact factor: 5.310

9.  Mst1 and Mst2 kinases: regulations and diseases.

Authors:  Funiu Qin; Jing Tian; Dawang Zhou; Lanfen Chen
Journal:  Cell Biosci       Date:  2013-08-28       Impact factor: 7.133

10.  Skewing of the population balance of lymphoid and myeloid cells by secreted and intracellular osteopontin.

Authors:  Masashi Kanayama; Shengjie Xu; Keiko Danzaki; Jason R Gibson; Makoto Inoue; Simon G Gregory; Mari L Shinohara
Journal:  Nat Immunol       Date:  2017-07-03       Impact factor: 25.606
View more
  3 in total

1.  Effects of non-vascularized adipose tissue transplantation on its genetic profile.

Authors:  Jeannine S Schreiter; L O Kurow; S Langer; M Steinert; L Massier
Journal:  Adipocyte       Date:  2021-12       Impact factor: 4.534

2.  Coding transcriptome analyses reveal altered functions underlying immunotolerance of PEG-fused rat sciatic nerve allografts.

Authors:  Tyler A Smith; Cameron L Ghergherehchi; Haley O Tucker; George D Bittner
Journal:  J Neuroinflammation       Date:  2020-10-02       Impact factor: 8.322

3.  Evaluation of local and circulating osteopontin in malignant and benign primary bone tumors.

Authors:  Ali Nazarizadeh; Shahin Alizadeh-Fanalou; Ameinh Hosseini; Alireza Mirzaei; Vahid Salimi; Hadi Keshipour; Banafsheh Safizadeh; Khodamorad Jamshidi; Mehrdad Bahrabadi; Masoumeh Tavakoli-Yaraki
Journal:  J Bone Oncol       Date:  2021-06-19       Impact factor: 4.072
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.